Award Timing Disclosure |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Mar. 04, 2025
USD ($)
shares
$ / shares
Rate
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Award Timing Disclosures [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Award Timing MNPI Disclosure | Timing of Equity Awards Our insider trading policy provides that equity awards granted under our equity compensation plans must generally be granted (a) during open trading windows, and (b) more than four business days before, and more than one business day after, our release of earnings for the most recently completed fiscal period or filing with the SEC. Consistent with our insider trading policy, we time the grant of our annual equity awards such that they are typically approved in January to be granted in March. Generally, these grants do not become effective until at least one business day after the release of earnings for the prior fiscal year. However, in 2025 we made the following grant of stock options to one of our named executive officers the business day following our release of earnings via our Form 10-K for the fiscal year 2024, filed on March 3, 2025:
In addition to our annual equity award grant in March, we also grant equity awards throughout the year for various reasons, including recruitment of new hires, promotions, and retention or recognition. In each case, we intend to grant equity awards during a time we believe there is no outstanding MNPI. |
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Award Timing Method | Consistent with our insider trading policy, we time the grant of our annual equity awards such that they are typically approved in January to be granted in March. Generally, these grants do not become effective until at least one business day after the release of earnings for the prior fiscal year. In addition to our annual equity award grant in March, we also grant equity awards throughout the year for various reasons, including recruitment of new hires, promotions, and retention or recognition. In each case, we intend to grant equity awards during a time we believe there is no outstanding MNPI. |
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Award Timing Predetermined | true | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Award Timing MNPI Considered | false | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Awards Close in Time to MNPI Disclosures, Table | However, in 2025 we made the following grant of stock options to one of our named executive officers the business day following our release of earnings via our Form 10-K for the fiscal year 2024, filed on March 3, 2025:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Susan Bobulsky | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Awards Close in Time to MNPI Disclosures | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Name | Susan Bobulsky | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Underlying Securities | shares | 180,029 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Exercise Price | $ / shares | $ 8.12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value as of Grant Date | $ | $ 997,325 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Underlying Security Market Price Change | Rate | 2.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||